ADVANCING CARE | ACCELERATING CURES
A NEW WAY TO LOOK AT MEDICINE
The Metrodora Institute brings together innovation and compassion along with revolutionary care all under one roof. Our mission is to fundamentally improve care and significantly accelerate pathways to cures.
The Metrodora Institute has created a truly interdisciplinary practice model that values all of our team members. We know we are only as good as our team and that does not just mean the very best in knowledge, experience, and skillset, but also the important qualities of care and empathy. As we set out to create a new blueprint for care and the relationships between patients and providers, we want to provide opportunities for like-minded individuals to be part of the change.
A NEW BLUEPRINT FOR CARE
Metrodora Institute is a destination medical clinic focused on the care and cure of complex multisystem disorders that broadly fall under the neuroimmune umbrella, such as many neurological disorders, autoimmune disorders, post-infectious disorders (i.e. long-COVID), gastrointestinal disorders (microbiota-neuroimmune axis), and connective tissue disorders.
Metrodora Institute is an integrated multidisciplinary clinic designed with the patient's comfort in mind with
all collaboratively working together. We also have a state-of-the-art ambulatory endoscopy center, relaxing infusion center, and a world class rehabilitation program.
The institute also includes a newly created, transformative research program that is focused on discovering better treatments, and ultimately cures, for patients suffering from these disorders. Our research team consists of geneticists, immunologists, neuroscientists, chemists, physicists, machine learning engineers, and data scientists. Our scientific team seamlessly partners with our clinicians and patients to revolutionize research in this area. We have also created the first data rich biobank specifically dedicated to these complex multisystem disorders. Our unique structure allows us to forge innovative partnerships with prestigious academic institutions as well as biotech and biopharma companies to accelerate research collaboratively and rapidly in this area.
A NAME WITH A PURPOSE
Metrodora is named after the first female physician to author a medical text (4th century AD), "On the Diseases and Cures of Women", which at the time significantly advanced women’s health. We seek to continue this tradition.
Our founding team is composed of world-renowned physicians, scientists, and technology leaders, positioning Metrodora as a world leader in the space of neuroimmune disorders and women’s health equity.
Laura A. Pace MD, PhD,
Co-Founder and CEO of Metrodora
Dr. Laura A. Pace is a Co-Founder and Chief Executive Officer of Metrodora. Laura is a Neurogastroenterologist with board certification from the American Board of Internal Medicine in both Internal Medicine and Gastroenterology, and from the United Council of Neurologic Subspecialties in Autonomic Disorders. She has been a leader in the rare disease space for many years and for the past several years has served as the Co-Lead for the adult program for the University of Utah NIH Undiagnosed Diseases Network (NIH UDN) clinical site, Medical Board member for Dysautonomia International and Chair of the Gastrointestinal Working Group for the International Consortium on Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders. Laura has a BS in Chemistry from Stony Brook University, a MD from the University of Illinois Chicago, and a PHD in Neuroscience from the University of Illinois at Urbana-Champaign. She has advanced research training in the areas of neuroscience, microbial physiology, evolution, and genetics, as well as analytical chemistry, studying host-microbe interactions. Additionally, she has advanced clinical training in medical genetics. She has published over 80 peer reviewed journal articles and has received research funding from the National Institutes of Health (NIH) and private foundations.
James Hemp PhD
Co-Founder and CSO of Metrodora
Dr. James Hemp is a Co-Founder and Chief Scientific Officer of Metrodora. James is an interdisciplinary scientist with over 20 years of research experience spanning biology, chemistry, physics, genetics, and medicine. He has published over 40 peer reviewed journal articles and has received research funding from the National Institutes of Health (NIH), National Science Foundation (NSF), and several private foundations. James received a BS in Honors Physics from the University of Minnesota and a PhD in Biophysics and Computational Biology from the University of Illinois at Urbana-Champaign. He was a prestigious Agouron Postdoctoral Fellow while at Caltech.
Fidji Simo, Metrodora
Co-Founder & President of the Metrodora Foundation
Fidji Simo is a Co-Founder of Metrodora and President of the Metrodora Foundation. She is Chief Executive Officer of Instacart and was previously the Head of Facebook App. She brings a wealth of expertise across business, technology, and advances in artificial intelligence that will position Metrodora as the most innovative research institute on such diseases. Fidji has been recognized by Fortune as part of their “40 under 40” annual ranking of most influential young people in business. She was also #2 on Fast Company’s 2017 list of Most Creative People in Business. Fidji was diagnosed with dysautonomia in 2020 and is committed to using her skills and large platform to cure these diseases.
COME BE PART OF THE CHANGE
We are seeking out unique individuals who will become the next thought leaders in their respective fields. Metrodora is situated in the heart of the valley bordered by the stunning Wasatch mountain range. Our choice to be situated in one of the most uniquely diverse areas of the country allow for appeal to outdoor enthusiasts, foodies, nightlife socialites, sports fans and more!